Home » Headlines » Currently Reading:

Morning Headlines 11/1/13

October 31, 2013 Headlines 1 Comment

Overrides of medication-related clinical decision support alerts in outpatients

A study published in JAMA looks at the value of clinical alerts within CPOE systems and finds that alerts are overridden 52 percent of the time. The most common alerts were duplicate drug (33.1%), patient allergy (16.8%), and drug–drug interactions (15.8%). The most likely alerts to be overridden were formulary substitutions, age-based recommendations, renal recommendations, and patient allergies.

MEDSEEK Acquires SymphonyCare to Expand Presence in Emerging Population Health and Care Management Market

Physician web portal and HIE vendor MEDSEEK acquires population health vendor SymphonyCare as part of a broader strategy to diversify its portfolio.

Merge Reports Third Quarter Financial Results

Merge reports Q3 results: revenue dropped to $57.7 million from $60.4 million during the same quarter last year,  missing analysts estimates on both revenue and EPS.

WebMD buys startup Avado to connect patients and physicians

As part of a strategic makeover aimed at rebranding itself a patient engagement platform, WebMD acquires Avado, a startup that develops cloud-based software that helps physicians and patients interact online.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there is "1 comment" on this Article:

  1. This paper is evidence that the CDS devices ought to be regulated for safety and efficacy by the FDA. Most of the drug interactions are nonsense, fifth order interactions.

    What was omitted from the paper and what is omitted from CDS devices is that when certain medications are stopped, others increase or decrease in potency, and there is NO warning of that.

    CDS devices fail to produce improved outcomes, wast professional time, and increase confusion. Moreover, they fail to warn when needed and fail to detect absurdity.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links